Background#R##N#Shared decision-making (SDM) is considered a key component of high quality cancer care and may be supported by patient decision aids (PtDAs). Many patients, however, face multiple social disadvantages that may influence their ability to fully participate in SDM or to use PtDAs; additionally, these social disadvantages are among the determinants of health associated with greater cancer risk, unwarranted variations in care and worse outcomes. The purpose of this systematic review is to describe the extent to which disadvantaged social groups in the United States (US) have been included in trials of cancer-related PtDAs and to highlight strategies, lessons learned and future opportunities for developing and evaluating PtDAs that are appropriate for disadvantaged populations.
['Kimberly R. Enard', 'Patricia Dolan Mullen', 'Geetanjali R. Kamath', 'Nickell M. Dixon', 'Robert J. Volk']
Are cancer-related decision aids appropriate for socially disadvantaged patients? A systematic review of US randomized controlled trials